BackARS Pharmaceuticals Overview

ARS Pharmaceuticals Total Revenue

Revenue analysis for SPRY.

Quarterly Revenue

$22.68M
↑ 184.47% YoY

As of Mar 2026

Annual Revenue (TTM)

$98.99M
↑ 3.52% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin